Patent · US Active

Process methods for phosphatidylinositol 3-kinase inhibitors

US10414737B2 · kind B2 · utility

4Cited by
72References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2018
Grant dateSep 17, 2019
Priority date
Expiry dateJul 2, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for the synthesis of quinazolinone containing compounds which may be useful for the treatment of cancer, is hereby disclosed. In addition, compound intermediates relating to these processes are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.